ClinicalTrials.Veeva

Menu

Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device

Rhaeos logo

Rhaeos

Status

Completed

Conditions

Hydrocephalus

Treatments

Device: FlowSense

Study type

Observational

Funder types

Industry

Identifiers

NCT06524492
2024-04

Details and patient eligibility

About

This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of functional implanted shunts and off-shunt locations will assess the diagnostic non-inferiority of the second-generation device to the first-generation device.

Enrollment

52 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  1. A ventricular CSF shunt with a region of overlying intact skin appropriate in size for application of the study device
  2. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
  3. Signed medical records release by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
  4. Verbal assent by minors 7 years of age and older who are able to understand the study and communicate their decision

Exclusion criteria

  1. Presence of an interfering open wound or edema in the study device measurement area
  2. Patient-reported history of serious adverse skin reactions to silicone-based adhesives
  3. Previous participation in a Rhaeos clinical study in which FlowSense device measurement data were acquired
  4. Patient or caregiver report of new or worsening symptoms of a possible shunt malfunction in the prior 7 days
  5. Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Trial design

52 participants in 1 patient group

FlowSense
Description:
This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of functional implanted shunts and off-shunt locations will assess the diagnostic non-inferiority of the second-generation device to the first-generation device.
Treatment:
Device: FlowSense

Trial contacts and locations

3

Loading...

Central trial contact

Anna Somera

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems